Several ASX-listed healthcare companies, many with relatively low market caps, are making strides in tackling cancers. ...
A cancer 'vaccine' developed by a Yale University scientist kept people's kidney cancer from recurring for three years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback